- Home
- BANR vs SUPN Comparison
BANR vs SUPN Comparison
Compare BANR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- SUPN
- Stock Information
- Founded
- BANR 1890
- SUPN 2005
- Country
- BANR United States
- SUPN United States
- Employees
- BANR N/A
- SUPN N/A
- Industry
- BANR Major Banks
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- BANR Finance
- SUPN Health Care
- Exchange
- BANR Nasdaq
- SUPN Nasdaq
- Market Cap
- BANR 2.3B
- SUPN 2.6B
- IPO Year
- BANR 1995
- SUPN 2012
- Fundamental
- Price
- BANR $67.20
- SUPN $45.66
- Analyst Decision
- BANR Buy
- SUPN Buy
- Analyst Count
- BANR 5
- SUPN 2
- Target Price
- BANR $70.75
- SUPN $43.00
- AVG Volume (30 Days)
- BANR 140.9K
- SUPN 654.2K
- Earning Date
- BANR 10-15-2025
- SUPN 11-03-2025
- Dividend Yield
- BANR 2.96%
- SUPN N/A
- EPS Growth
- BANR 9.13
- SUPN 1411.53
- EPS
- BANR 5.25
- SUPN 1.14
- Revenue
- BANR $624,024,000.00
- SUPN $665,125,000.00
- Revenue This Year
- BANR $0.95
- SUPN $4.84
- Revenue Next Year
- BANR $6.48
- SUPN $17.69
- P/E Ratio
- BANR $12.34
- SUPN $38.93
- Revenue Growth
- BANR 5.10
- SUPN 5.55
- 52 Week Low
- BANR $54.01
- SUPN $29.16
- 52 Week High
- BANR $78.05
- SUPN $46.79
- Technical
- Relative Strength Index (RSI)
- BANR 56.24
- SUPN 62.59
- Support Level
- BANR $63.95
- SUPN $43.44
- Resistance Level
- BANR $67.25
- SUPN $46.72
- Average True Range (ATR)
- BANR 1.45
- SUPN 1.12
- MACD
- BANR -0.18
- SUPN -0.41
- Stochastic Oscillator
- BANR 66.43
- SUPN 68.96
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.